# Amgen Inc. (AMGN) — Q4-2024 Earnings Results

**Report date:** 2025-02-04 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2024

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Up 0.05%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $5.31 | N/A | +5.59% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in the company's core products. They emphasized their commitment to innovation and market leadership.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They noted ongoing investments in R&D to drive future growth.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report shows a positive surprise on EPS, indicating better-than-expected profitability. The slight increase in stock price suggests that investors reacted favorably to the earnings beat, despite the lack of revenue data and guidance. Management's focus on R&D and core product performance may signal a strategy for sustained growth moving forward.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2024_